Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Hlatky

Circulation

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Circulation|April 6, 2011
Persistent racial disparities in survival after heart transplantationVincent Liu, Jay Bhattacharya, David Weill, et al.
Circulation|November 19, 2011
Physician procedure volume and complications of cardioverter-defibrillator implantationJames V Freeman, Yongfei Wang, Jeptha P Curtis, et al.
Circulation|September 30, 2010
Cost-effectiveness of using high-sensitivity C-reactive protein to identify intermediate- and low-cardiovascular-risk individuals for statin therapyKeane K Lee, Lauren E Cipriano, Douglas K Owens, et al.
Circulation|October 4, 2012
Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United StatesBenjamin A Goldstein, Cristina M Arce, Mark A Hlatky, et al.
Circulation|February 13, 2002
Cost-effectiveness of a conservative, ischemia-guided management strategy after non-Q-wave myocardial infarction: results of a randomized trialPaul G Barnett, Shuo Chen, William E Boden, et al.
Circulation|November 19, 2009
Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trialMark A Hlatky, Derek B Boothroyd, Kathryn A Melsop, et al.
Circulation|September 13, 2006
Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patientsKevin T Stroupe, Douglass A Morrison, Mark A Hlatky, et al.
Circulation|November 4, 2017
Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation)William F Fearon, Takeshi Nishi, Bernard De Bruyne, et al.
Circulation|August 27, 2003
Differences in medical care and disease outcomes among black and white women with heart diseaseAshish K Jha, Paul D Varosy, Alka M Kanaya, et al.
Circulation|October 13, 2010
Health status after treatment for coronary artery disease and type 2 diabetes mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trialMaria Mori Brooks, Sheng-Chia Chung, Tarek Helmy, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Circulation|April 6, 2011
Persistent racial disparities in survival after heart transplantationVincent Liu, Jay Bhattacharya, David Weill, et al.
Circulation|November 19, 2011
Physician procedure volume and complications of cardioverter-defibrillator implantationJames V Freeman, Yongfei Wang, Jeptha P Curtis, et al.
Circulation|September 30, 2010
Cost-effectiveness of using high-sensitivity C-reactive protein to identify intermediate- and low-cardiovascular-risk individuals for statin therapyKeane K Lee, Lauren E Cipriano, Douglas K Owens, et al.
Circulation|October 4, 2012
Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United StatesBenjamin A Goldstein, Cristina M Arce, Mark A Hlatky, et al.
Circulation|February 13, 2002
Cost-effectiveness of a conservative, ischemia-guided management strategy after non-Q-wave myocardial infarction: results of a randomized trialPaul G Barnett, Shuo Chen, William E Boden, et al.
Circulation|November 19, 2009
Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trialMark A Hlatky, Derek B Boothroyd, Kathryn A Melsop, et al.
Circulation|September 13, 2006
Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patientsKevin T Stroupe, Douglass A Morrison, Mark A Hlatky, et al.
Circulation|November 4, 2017
Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation)William F Fearon, Takeshi Nishi, Bernard De Bruyne, et al.
Circulation|August 27, 2003
Differences in medical care and disease outcomes among black and white women with heart diseaseAshish K Jha, Paul D Varosy, Alka M Kanaya, et al.
Circulation|October 13, 2010
Health status after treatment for coronary artery disease and type 2 diabetes mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trialMaria Mori Brooks, Sheng-Chia Chung, Tarek Helmy, et al.
Pageof 2